Skip to content

Clinical trials

Atherosclerosis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Netherlands Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20042
20054
20076
20085
20099
20103
20116
20126
20132
20145
20154
20164
20173
20184
20192
20203
20215
20228
20231
20245
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Recruiting13
Unknown status12
Active, not recruiting8
Terminated4
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center11
Radboud University Medical Center10
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)8
Eli Lilly and Company6
GlaxoSmithKline5
UMC Utrecht5
Amgen4
Novartis Pharmaceuticals4
AstraZeneca3
NewAmsterdam Pharma3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis101
Coronary Artery Disease26
Cardiovascular Diseases23
Dyslipidemias9
Hypercholesterolemia8
Myocardial Infarction8
Peripheral Arterial Disease8
Coronary Disease6
Hyperlipidemias6
Stroke6

Trials

Showing 51 to 75 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.